Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
p53 peptide vaccine immunotherapy in previously treated metastatic colorectal cancer
ISRCTN43704292Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2006
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of p53 peptide-loaded dendritic cell vaccine (University of Pittsburgh) in colorectal cancer (CRC), sponsored by Leiden University Medical Center. Started Nov 2006; status: completed.
02
Drugs
p53 peptide-loaded dendritic cell vaccine (University of Pittsburgh)
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN43704292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43704292.